Fact-check · Sep 28, 2026 · Donald Trump
“Eli Lilly is spending billions”
TRUE
What the record shows
Eli Lilly reported capital expenditures of $7.8 billion in 2025 (10-K filing). The company has committed over $50 billion in U.S. capital expansion since 2020 and announced $20+ billion in acquisitions in 2026.
Sources
- Eli Lilly Doubles Capital Spending On US Drug Manufacturing With $50 Billion Target (CORRECTED)
- Eli Lilly Commits Over $20 Billion to Acquisitions in 2026 Expansion Drive - Bloomberg
- Lilly inflates US facility investment spending by $4.5bn | pharmaphorum
- Lilly expands US manufacturing build-out with $50B target | BioPharma Dive
- LILLY ELI & CO - Form 8-K - FY2010
- LILLY ELI & CO - Form 8-K/A - FY2012
From: President Trump Makes an Announcement, Sep. 28, 2026
Vote Unbiased checks what officials say against government data — BLS, BEA, Census, Treasury, the Fed — with sources cited. Every speaker, every party, same standard. See the data →